Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Chemours Co (CC) Surging As Another Analyst Moves into the Bull Column

Chemours Co (NYSE:CC) shares have surged another 2.5% in the pre-market after Laurence Alexander of Jefferies upgraded his rating on the chemicals producer to ‘Buy’ from ‘Hold’. The analyst also increased his price target to $48 per share, from the previous $35. As reason for the upgrade, Alexander thinks that longer term structural improvements in the titanium dioxide and fluoropolymers market could unlock even more wealth for shareholders. In addition the analyst notes that although shares of Chemours Co (NYSE:CC) have had a rally for the ages over the past year due to litigation relief and cyclical leverage, the stock still sports an around 8% free cash flow yield.

Sentiment in the stock has been strong due to the broader bull market and the news that Chemours Co (NYSE:CC) recently hiked the worldwide price for all its fluoropolymer chemical products by up to 10%. News of the upgrade has improved sentiment even further.

What Does The Smart Money Sentiment Say?

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 39.7% gains over the past 12 months and outperformed the 24.1% gain enjoyed by the S&P 500 ETFs. Our enhanced small-cap hedge fund strategy returned more than 45% over the last 12 months and outperformed SPY by more than 30 percentage points over the last 4.5 years (see details here).

Smart money sentiment around the chemicals producer has been relatively stable. Of the 742 top funds we track, 29 were long Chemours Co (NYSE:CC) at the end of the fourth quarter, down 2 funds from the previous quarter.

The Bottom Line

Despite soaring 64% year-to-date and over 400% over the last four quarters, Jefferies thinks there is still more upside for Chemours Co (NYSE:CC) ahead.

Follow Chemours Co
Trade (CC) Now!


stock market, new york, wall street, banking, trade


DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.